Details Behind Viral Conspiracy Theory Merck Publicly Smeared Ivermectin Because of Molnupiravir Antiviral Pill
You’ve probably heard the news by now that German drug maker Merck has allegedly developed an experimental COVID-19 pill that can cut the risk of hospitalization and death in half. The name of Merck’s new drug is Molnupiravir, and the results of their studies on it have not been peer reviewed. What some people find strange about the situation ties into Merck’s other drug Ivermectin, which also allegedly does the same thing as their new pill, and is used in some countries as treatment.
Did Merck Publicly Smear Ivermectin to Make Way for Their New Drug Molnupiravir?
Merck has stopped clinical trials of their Molnupiravir on grounds that the results are so profound that it should be authorized for emergency use. According to results of their studies around 7% of people who took Molnupiravir were hospitalized or died from COVID, compared to 14% who took a placebo.
What’s strange to some people is that Merck publicly smeared their own Ivermectin pill despite it allegedly showing similar levels of effectiveness in people who took it after being infected with COVID-19. Some people believe Merck was smear campaigning their own drugs, because they were in development of a new more expensive drug that had no generic versions, and new patent.
Here is what Merck said in a past statement regarding their Ivermectin drug for use as COVID-19 treatment,
- It has No scientific basis for a potential therapeutic effect against COVID-19 from pre-clinical studies;
- It has No meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease, and;
- It has a concerning lack of safety data in the majority of studies.
Conspiracy theorists believe Merck was supporting the public smear campaign of Ivermectin, because it would have interfered with the need of their new Molnupiravir pill with a new patent.
The Cost of Merck’s Ivermectin vs Merck’s Molnupiravir Antiviral Pill
At the moment you can get the generic version of Merck’s Ivermectin for around $45 for a box of eight pills, or $79 for a box of 20 pills. If you do that math that’s around $4 to $7 per pill. On the flipside the US government has made an advanced purchase of 1.7 million doses of Merck’s Molnupiravir drug for around $1.2 Billion. If you do the math that’s around $700 per dose of Molnupiravir.
It’s easy to see Molnupiravir brings Merck way more profit than Ivermectin. Could that really be the reason Merck publicly smeared its own drug Ivermectin for COVID treatment? For most large companies money is always the motive.
Author: JordanThrilla Staff
Explore Related Articles
Controversial Washington DC Whole Foods with Four Scan Policy Goes Viral
A video of a customer’s experience at a Whole Foods store in Washington DC has gone viral on social media, showing how the store requires customers to scan four different times before leaving the premises. The video, which was posted by a user on Twitter sparked millions of reactions.
When...
Here’s What Happened to the IndiGo Flight Passenger Who Slapped Pilot...
The tranquility of a routine flight was shattered when an IndiGo passenger, Sahil Kitaria, slapped the pilot, Anup Kumar, in an incident that has since sent shockwaves through the aviation industry. Many people are wondering what happened to the passenger after his unruly actions, well we have all the...
Woman’s Story about 4 Morbius Tickets Goes Viral
If you've looked at the reviews for the new Morbius movie recently then you've probably noticed majority of them are talking about how bad the movie is. Some people predicted it wouldn't be a good movie after learning Jared Leto would be the lead actor, and now many people...
